RHI · Robert Half Inc. · Stock research

Current Thesis

Robert Half is a cyclical white-collar staffing incumbent stuck in a multi-quarter earnings recession. Q2 2026 (reported 2026-07-23): EPS $0.26 inline, revenue $1.336B a whisker over the $1.322B estimate. Q3 guide is EPS $0.43–$0.53 vs $0.47 consensus and sales $1.310B–$1.410B a midpoint roughly in line but a range wide enough to signal management has little demand visibility. The stock still sold off 2026-07-24 despite the revenue beat. Goldman reiterated Sell (PT lifted $26→$29 on 2026-07-24) while Truist held Buy (PT $50, 2026-07-22) a ~72% target spread that marks a genuinely contested, unresolved cyclical bottom. The narrative here is breaking, not accelerating. This is a value-trap watch item, not the kind of momentum long this playbook exists to catch.

Bullish and bearish views on Robert Half Inc.

The model's bull view on Robert Half Inc. (RHI), in brief: Top-line bleed is slowing: Q2 revenue $1.336B edged past the $1.322B estimate (2026-07-23), the first hint the sequential decline is flattening. The bear view: EPS has more than halved: $0.26 in Q2 against the >$1 quarterly run-rate of the last upcycle earnings power is structurally impaired. Both cases follow in full.

Bull Case

• Top-line bleed is slowing: Q2 revenue $1.336B edged past the $1.322B estimate (2026-07-23), the first hint the sequential decline is flattening.
• Q3 guide midpoint (~$0.48 EPS, ~$1.36B sales) implies EPS steps up off the depressed $0.26 Q2 trough.
• Protiviti (the risk/consulting arm) is the higher-margin, less-cyclical engine and a structural offset to contract-staffing softness.
• Truist Buy, PT $50 (2026-07-22) prices the cyclical-recovery upside if white-collar hiring thaws into 2027.
• A >5% dividend yield plus a historically net-cash balance sheet offers a paid-to-wait carry conditional on the payout holding.
• Staffing volumes are an early-cycle mover; a Fed easing path has historically front-run a rebound in placement demand.

Bear Case

• EPS has more than halved: $0.26 in Q2 against the >$1 quarterly run-rate of the last upcycle earnings power is structurally impaired.
• AI automation is a secular, not cyclical, headwind and hits exactly the finance, accounting, admin, and contract-tech roles RHI places.
• Goldman reiterated Sell twice this month (PT $26 on 2026-07-14, raised to $29 on 2026-07-24) the bear target still sits ~28% under where high-yield screens place the stock.
• The 2026-07-24 drop came on a revenue beat, meaning the tape is discounting both the guide and the quality of any recovery.
• The >5% yield is a value-trap signal: it is elevated because price collapsed, and dividend-cut risk rises if the earnings recession runs into 2027.
• A wide Q3 guide ($0.43–$0.53) is what low-visibility looks like, and low-visibility guides tend to precede downward revisions.

Setup & Price Structure

• Secular downtrend intact; the tape has rolled over across multiple quarters the opposite of an accelerating-narrative setup.
• The 2026-07-16 one-day pop (RHI tagged in the "moving higher" group) faded straight into the 2026-07-24 post-earnings drop a failed bounce inside a downtrend.
• Analyst band runs $29 (Goldman, bear) to $50 (Truist, bull); price sits in the lower half, pulled gravitationally toward the Sell target near $29.
• No base, no higher-low sequence, no breakout retest nothing a momentum entry keys on. A long at these levels is bottom-fishing a falling knife.
• Beginner-trap read: high dividend yield plus a "cheap" optical multiple plus a beaten-down price is the classic value-trap quadrant, not a setup.

Catalyst Calendar (next 30 days)

• ~2026-08-07 (est.): monthly BLS jobs report; JOLTS follows mid-month labor-market prints are the real swing factor for a staffing name, and further white-collar softening pressures the stock.
• ~2026-08 (est.): quarterly dividend declaration / ex-dividend window (RHI has historically declared around mid-August); any payout change is the tell on balance-sheet stress a cut confirms the bear case.
• No dated company-specific momentum catalyst inside the 30-day window. Next binary is Q3 2026 earnings, ~2026-10-22 (est.), well outside it.

Elapsed catalysts

• 2026-07-23: Q2 2026 earnings ALREADY REPORTED (EPS $0.26, revenue $1.336B). The binary is behind the tape. _(passed 3d ago)_

What Would Change Our Mind

• Two consecutive quarters of sequential revenue AND EPS growth, confirming a cyclical trough that would justify a cyclical-recovery long.
• A weekly close back above ~$50 on expanding volume, reclaiming the Truist target and breaking the downtrend a structural inflection worth chasing.
• Evidence Protiviti is scaling fast enough to offset staffing declines (segment growth north of ~15% in a print).
• A labor-market re-acceleration JOLTS white-collar openings turning up the leading indicator for placement volume.

Correlation Notes

• Moves with staffing/labor peers: MAN (ManpowerGroup, tagged higher alongside RHI on 2026-07-16), plus ASGN, KFRC, HSII, RHI-adjacent professional-staffing names. This is a sector cyclical bet rather than an idiosyncratic story.
• Inversely exposed to the AI-labor-displacement narrative the automation story that lifts AI names is a structural drag on white-collar placement demand.
• Rate-sensitive: a Fed easing cycle that revives corporate hiring is the macro key; a "higher-for-longer" regime extends the earnings recession.
• The seeded theme "managed-care-health-services" is a classification error no read-through to managed-care or health names; the correct peer set is professional staffing.